Research and Development

Excilone leverages its expertise in research and development of new technologies, aiming to provide its customers with cutting-edge, precise sample analysis techniques.

Through our R&D initiatives, our goal is to help accelerate research
dedicated to the discovery of new biomarkers for complex diseases such as cancer.
Our commitment aims to improve the early detection and diagnostic accuracy of these diseases.

Whether independently or in collaboration with renowned academic institutions, our R&D teams develop innovative methods aimed at reducing analysis scales.
This work opens up new possibilities for cellular and tissue exploration.

At the same time, we are strengthening the traceability and efficiency of sample analyses thanks to our dedicated team of software developers and engineers.